Related Experiment Video
Updated: Jan 11, 2026

Noninvasive Assessment of Cardiac Abnormalities in Experimental Autoimmune Myocarditis by Magnetic Resonance Microscopy Imaging in the Mouse
Published on: June 20, 2014
Immune Checkpoint Inhibitor-Associated Myocarditis Mimicking Takotsubo Cardiomyopathy
Satoru Hiromasa1, Yoshimichi Ueda2, Takuya Mayumi1
1Department of Cardiology, Keiju Medical Center, Nanao, Japan.
Pembrolizumab-induced myocarditis, a rare immune-related adverse event, can mimic Takotsubo cardiomyopathy. Early diagnosis via endomyocardial biopsy and steroid treatment are crucial for improving outcomes in patients receiving immune checkpoint inhibitors.
Area of Science:
- Oncology
- Cardiology
- Immunology
Background:
- Pembrolizumab-induced myocarditis is a rare but potentially fatal immune-related adverse event.
- Immune checkpoint inhibitors (ICIs) are increasingly used in cancer treatment.
- Myocarditis associated with ICIs presents a diagnostic challenge.
Related Concept Videos
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis I: Introduction
Myocarditis III: Medical Management
Myocarditis IV: Nursing Management
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy I: Introduction and Classification

